Full Program Just Released!
Your Flagship Event Driving ADC Innovation, Insights & Connections

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
Bristol Myers’ $800M bispecific ADC aces China breast cancer study, putting TROP2 drugs on notice
Regeneron pens $2.3B pact with Parabilis to develop new type of ADC-like therapy
Daiichi, AstraZeneca’s Enhertu breaks into early breast cancer with dual FDA approvals

Ao Ji

Ao Ji

Chief Scientific Officer Suzhou BioReinnnovation

Seminars

Wednesday 14th October 2026

MCLICK: Empowering Mono & Dual Payload AXC Innovation via a Pure Chemo Approach

12:30 pm

Achieving highly selective reduction of inter-chain S-S bonds in IgG1
Leveraging MCLICK to enable AXC with various DARs and ratios
Empowering AXC innovation with MCLICK and other platforms

Ao Ji - Speaker at 17th World ADC San Diego Summit

View all Speakers

View Event Brochure